StimAire

StimAire is a medical device company developing a minimally invasive neurostimulation treatment for obstructive sleep apnea that does not require CPAP, mouthpieces, or traditional surgery. Its device uses a tiny, battery-free injectable receiver/stimulator that modulates peripheral nerves such as the hypoglossal nerve, activated wirelessly by an external wearable. The company completed its first-in-human clinical trial in October 2023.